News

She will also serve as Associate Chief of the Division of Hematology/Oncology at Boston Children’s Hospital

Dana-Farber/Boston Children’s is honored to have 11 faculty members named part of Boston magazine’s "Top Doctors" for 2025.

U.S. News & World Report has again recognized Dana-Farber/Boston Children's Cancer and Blood Disorders Center as the #2 pediatric cancer program in the nation in its 2024-25 Best Children's Hospitals report.

Dana-Farber/Boston Children’s Cancer and Blood Disorder Center is happy to announce three research fellows have been named as part of the Inaugural class of Damon Runyon–St. Jude Pediatric Cancer Research Fellows.

Dana-Farber/Boston Children’s is honored to have 12 faculty members named part of Boston magazine’s “Top Doctors” for 2024.

Lisa Diller, MD, Chief Medical Officer at the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, has been named an Innovator in Healthcare for Research by the Boston Business Journal.

Stuart H. Orkin, MD has been awarded the third Elaine Redding Brinster Prize in Science or Medicine for his landmark discoveries of the molecular basis of blood disorders and using the basic science findings for therapeutic approaches

U.S. News & World Report has named Dana-Farber/Boston Children's Cancer and Blood Disorders Center the #2 pediatric program in the nation in its 2023-24 Best Children's Hospitals report.

Boston magazine has named numerous Dana-Farber/Boston Children’s Cancer and Blood Disorders Center faculty members to its annual "Top Doctors" guide.

After an extensive national search, it is with great pleasure that Dana-Farber/Boston Children's Cancer and Blood Disorders Center introduces Abby R. Rosenberg, MD, MS, MA, as the new Chief of Pediatric Palliative Care at Dana-Farber Cancer Institute and Director of Palliative Care at Boston Children’s Hospital.